We have synthesised, characterised and examined the cytotoxicity of [(1,10- phenanthroline)(1R,2R,4R/1S,2S,4S-4-methyl-cyclohexanediamine) platinum(II)]2+ (PHEN-4-MeDACH) in the L1210 cell line. The cytotoxicity of PHEN-4-MeDACH in the murine leukaemia (L12010) cell line was 1.8 ± 0.00 μM, comparable with that of [(1,10-phenanthroline)(1R,2R-diaminocyclohexane) platinum(II)]2+ (1.5 ± 0.14 μM) but less cytotoxic than [(1,10-phenanthroline)(1S,2S-diaminocyclohexane)platinum(II)]2+(0.15 ± 0.06 μM) and cisplatin (0.43 ± 0.06 μM)
This report describes the synthesis, characterization and biological activity of a series of platinu...
This report describes the synthesis, characterization and biological activity of a series of platinu...
We have developed six dihydroxidoplatinum(IV) compounds with cytotoxic potential. Each derived from ...
This study documents the first detailed investigation into the relationship between molecular struct...
Four platinum(II) metallointercalating complexes of 1,10-phenanthroline (phen) with the chiral ancil...
Among the emerging anti-cancer compounds, phenanthroline derivatives are of high interest. In contra...
The cytotoxicity of platinum(II) complexes coordinated to a chiral diamine, 1S,2S-diaminocyclohexane...
Fifteen platinum(II)-based metallointercalators have been synthesised that utilise substituted 1,10-...
Platinum complexes of the type [Pt(PL)(AL)]2+ where PL is a derivative of 1,10-phenanthroline and AL...
Fifteen platinum(II)-based metallointercalators have been synthesised that utilise substituted 1,10-...
Platinum complexes of the type [Pt(PL)(AL)]2+ where PL is a derivative of 1,10-phenanthroline and AL...
Fifteen platinum(II)-based metallointercalators have been synthesised that utilise substituted 1,10-...
Fifteen platinum(II)-based metallointercalators have been synthesised that utilise substituted 1,10-...
Twelve metallointercalators of the type [Pt(IL)(AL)](2+), where A(L) is either the R,R or S,S enanti...
Fifteen platinum(II)-based metallointercalators have been synthesised that utilise substituted 1,10-...
This report describes the synthesis, characterization and biological activity of a series of platinu...
This report describes the synthesis, characterization and biological activity of a series of platinu...
We have developed six dihydroxidoplatinum(IV) compounds with cytotoxic potential. Each derived from ...
This study documents the first detailed investigation into the relationship between molecular struct...
Four platinum(II) metallointercalating complexes of 1,10-phenanthroline (phen) with the chiral ancil...
Among the emerging anti-cancer compounds, phenanthroline derivatives are of high interest. In contra...
The cytotoxicity of platinum(II) complexes coordinated to a chiral diamine, 1S,2S-diaminocyclohexane...
Fifteen platinum(II)-based metallointercalators have been synthesised that utilise substituted 1,10-...
Platinum complexes of the type [Pt(PL)(AL)]2+ where PL is a derivative of 1,10-phenanthroline and AL...
Fifteen platinum(II)-based metallointercalators have been synthesised that utilise substituted 1,10-...
Platinum complexes of the type [Pt(PL)(AL)]2+ where PL is a derivative of 1,10-phenanthroline and AL...
Fifteen platinum(II)-based metallointercalators have been synthesised that utilise substituted 1,10-...
Fifteen platinum(II)-based metallointercalators have been synthesised that utilise substituted 1,10-...
Twelve metallointercalators of the type [Pt(IL)(AL)](2+), where A(L) is either the R,R or S,S enanti...
Fifteen platinum(II)-based metallointercalators have been synthesised that utilise substituted 1,10-...
This report describes the synthesis, characterization and biological activity of a series of platinu...
This report describes the synthesis, characterization and biological activity of a series of platinu...
We have developed six dihydroxidoplatinum(IV) compounds with cytotoxic potential. Each derived from ...